Australia's largest stock trading and investment forum Australia's #1 stock forum

CGB

Click for more information

0.00%

2.1¢ cann global limited

Hi Bas,Yes, I was a long term holder of this company? however...

First 55 Last

Share
Profile

Follow
dapper4343

3,125 Posts.

145

05/05/20

13:17

Post #: 44441653
Share

Originally posted by Basileus: ↑

"It cost money to make money selling retail."

A rather familiar cliche.

Q. I wonder if you, or anyone for that matter, can shed some light on the material below?

Item : 2.3 Cash flows from loans to other entities -131 i.e. $131,000

Q. Who to and what for?

AND

Item : 7.2 Aggregate amount of cash flow from loans to these parties included in item 2.3

Q. Why does that item contain no entry?

Q. If, that loan had been made to a related party, then why is not listed as such?

They receive $428k in receipts from customers. And they loan $131,000 out to some, as yet, unidentified party.

AND

Item : 9.1 Research and development 1,000 i.e. $1,000,000

Q. Why be giving this money away in at time when you are losing money?

Q. And why is the R&D budget allocated to only one avenue?

They make $428,000 in revenue and they send $1,000,000 for a research program - staggering.

AND

Item : 9.3 Advertising and marketing 40 i.e. $40,000

Q. Why such a small amount on advertising and marketing? Any wonder that has only been 428k in sales?

So ... between loans to other parties and research ($1,131,000) they can only find $40,000 advertising and marketing?

AND

Item : 4.6 Cash and cash equivalents at end of quarter 6,988 i.e. $6,988,000

Q. If the current pattern of this quarterly were replicated for ... say ... the next 4 quarterlies - who would be the biggest beneficiaries of the remaining $6,988.000?

Given the bank balance it seems rather odd that $862,000 was acquired via the issue of convertible notes?

Observations

1. Whilst this quarterly speaks for itself and hardly requires any detailed debate - I wonder if there's anyone posting here that can still find a way to support this quarterly in particular and the decision making of the company, generally?

2. It seems to me that it is the same pattern of decision making that is reflected in previous financial reports.

3. The recipient of the $131,000 worth of loans ought to have been identified - question is why hasn't that been noted?

4. What's the old saying, ".. fool me once ... shame on you, fool me twice ... shame on me!"

5. I see that another poster is going to make some enquiries on the apparent disparity between items 2.3 and 7.2 - that, in my view, is a line of enquiry that is well worth pursuing.

6. I appreciate that some the pro posters may have disappeared but I believe that we actually need them here on the CGB thread. It has been my observation that what tends to happen is that they (previous posters holders) disappear and the share register turns over and who does that ultimately benefit?

n.b @jgreen31 "How do expenses compare?"

You should have a look (APH) - the loans to other entities and admin costs - that might be a good place to start!

Expand

Hi Bas,
Yes, I was a long term holder of this company? however after doing a great deal more investigation into their finances, plus the staggering number of stuff ups in their reporting I decided late last year to finally accept the fact that it was a very bad investment decision on my behalf and sold out!
I thought out of curiosity that I would have a look at their latest report and after perusing that congratulated myself on finally accepting the fact that nothing has changed.
I like all other investors don't like losing money, which I did with CGB however I feel quite happy with that decision in light of what appears to be a company that needs investigating by ASIC or the ASX based on this latest report and lack of detail re loans?
I enjoyed reading your posts as you gave a more rounded perspective on this company rather than those that are one eyed.
Cheers
dapper

CGB Price at posting: 0.7¢ Sentiment: None Disclosure: Not Held
13 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 26 more messages in this thread...

First 55 Last

Add CGB (ASX) to my watchlist